AbCellera to Report Third Quarter 2021 Financial Results on November 9, 2021
AbCellera (Nasdaq: ABCL) will release its third quarter 2021 financial results on November 9, 2021, followed by an earnings call at 2:00 p.m. PT (5:00 p.m. ET). The live conference can be accessed through AbCellera’s Investor Relations website, where a replay will also be available. AbCellera is a technology firm that aids in the discovery and development of antibodies for drug development by collaborating with a range of pharmaceutical and biotechnology partners.
- None.
- None.
The live webcast of the earnings conference will be available through a link that will be posted on AbCellera’s Investor Relations website. A replay of the webcast will be available through the same link following the conference call.
About
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, visit www.abcellera.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20211014006060/en/
Media:
Investor Relations:
Source:
FAQ
When will AbCellera announce its third quarter 2021 financial results?
What time is the AbCellera earnings conference call scheduled?
Where can I find the webcast for AbCellera's earnings call?
What is the stock symbol for AbCellera?
